KAM
ABBV icon

Knightsbridge Asset Management’s AbbVie ABBV Stock Holding History

Knightsbridge Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$871K Buy
4,007
+99
+3% +$22K 0.12% 92
2025
Q4 		$893K Buy
3,908
+234
+6% +$53.3K 0.14% 77
2025
Q3 		$851K Buy
3,674
+867
+31% +$177K 0.14% 73
2025
Q2 		$521K Buy
2,807
+997
+55% +$185K 0.11% 86
2025
Q1 		$379K Buy
1,810
+656
+57% +$128K 0.1% 97
2024
Q4 		$205K Buy
+1,154
New +$212K 0.05% 114

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Knightsbridge Asset Management's ABBV Position: Q1 2026 in Review

Knightsbridge Asset Management increased its AbbVie (ABBV) stake by 2.5% in Q1 2026, buying an estimated $22K and bringing the position to 4,007 shares worth $871K. The position accounts for 0.12% of the portfolio, ranked #92.

Knightsbridge Asset Management first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $893K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Knightsbridge Asset Management held 4,007 shares of AbbVie worth $871K as of Q1 2026.
  • Knightsbridge Asset Management bought 99 AbbVie shares in Q1 2026, an estimated $22K.
  • AbbVie made up 0.12% of Knightsbridge Asset Management's portfolio in Q1 2026, its #92 holding.
  • Knightsbridge Asset Management first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Knightsbridge Asset Management's AbbVie position peaked at $893K in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Knightsbridge Asset Management's 13F filing for Q1 2026, filed 15 May 2026.